43 / 78
LISI 2016 ANNUAL REPORT
I
39
QUESTIONS TO
OLIVIER LE BARS
CEO, LISI MEDICAL
“The current
movement of concentration
could still be able
to offer opportunities for LISI MEDICAL”
What is the position of LISI MEDICAL at
the end of 2016?
_ The year 2016 was of course marked by
the acquisition of LISI MEDICAL Remmele,
which made it possible to double the
size of the division. This operation
allows us to acquire strong positions on
the market of medical equipment and
minimally invasive surgery that we were
otherwise unable to achieve as quickly. It
is reinforcing our positions substantially
and is getting us back closer to the great
equipment makers in orthopaedic health,
in search of partners who are able to offer
large product and service catalogues with
high added value.
Howwill it be possible to organize the
new consolidation scope?
_ The buyout of REMMELE Medical
Operations has allowed us to project the
plants of the former scope in France and
the US based on new market segments.
The production techniques are similar
and we now benefit from a solid point of
entry for major clients in bone surgery.
We will now pursue the development of
generic products, initiated in 2015, with
packaged and sterilized
prostheses, ready to be used in an
operating theater. The organization of
sites, for its part, will not change much.
The support, purchasing and industry
functions have been bolstered to activate
synergies between the various sites of the
division.
What is the outlook for 2017?
_ The concentration movement is set to
continue in the medical equipment sector
in the broad sense, which includes a large
number of extremely dynamic growing
companies, some of them small startup
companies. This context might be able
to offer some wonderful opportunities
for LISI MEDICAL, wh ich needs to
bolster its positions. With regard to
LISI MEDICAL Remmele, the integration
and convergence of standards is set to
continue in 2017 with the launch of the
LEAP and E-HSE operating excellence
programs for the hygiene and safety
segment. An extension of 4,500 m
2
is now
planned at Big Lake, one of LISI MEDICAL
Remmele’s two plants, so as to meet its
growth needs.